Société de recherche sur le cancer

 
 
 
402 - 625, avenue du Président-Kennedy
Montréal, Québec
Canada
H3A 3S5
Sigle : CRS
Adresse Internet : http://www.cancer-research-society.ca

  Programme(s) de recherche actif(s)

  Projet(s) actif(s)
    Characterisation of PTM-associated mutations that alter signaling network in breast and ovarian cancers
    Characterization of the role of the Yin Yang1 (YY1) transcription factor in pleuropulmonary blastoma
    Deciphering mechanical stress-induced nuclear envelope remodeling in tumor cells
    Deciphering the signalling cascade mediating basal cell carcinoma progression
    Defining the mechanism of oncometabolite-mediated DEPTOR degradation in brain cancer
    Engineering HPV oncoprotein E6 for inhibitors of cancer progression
    Identification and validation of compounds targeting tumor growth and cancer-induced cachexia
    Interaction between environment, diet, physical activities, and sexual habits, in the risk of prostate cancer. Validation of biomarkers to personnalize preventive interventions.
    Pharmacogene methylation profiling during acute lymphoblastic leukemia treatment
    Récepteur 2B de la sérotonine (HTR2B) : mode de régulation et contribution aux propriétés métastatiques du mélanome uvéal
    Sex steroids as modulators of the prostate cancer immune microenvironment
    The role of differential cell contractility mediated by Tissue Transglutaminase 2 in regulating the crosstalk between extracellular matrix stiffness and EGF
    Using BET bromodomain inhibitors to create phenotypic lethality in melanoma
www.ulaval.ca